Post-earnings recap
Reported
Thu, Aug 6, 2026
EPS actual
$0.19
EPS est.
$0.07
EPS surprise
+153.33%
1-day move
-8.18%
Privia Health Group reported a surprising earnings per share of $0.19, significantly above expectations. However, the stock reacted negatively, dropping 8.18%. This decline may reflect investor concerns despite the strong EPS performance, as revenue details and future guidance were not provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.19 | N/A | +153.33% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
Privia Health Group, Inc. operates in the health care sector, focusing on providing technology-driven solutions for healthcare services. As a company with a market cap of $3 billion, it plays a significant role in improving patient care and streamlining healthcare operations, which is increasingly important as the industry shifts towards more integrated and efficient models.
Last quarter
In Q1-2026, Privia Health reported an EPS of $0.19, significantly exceeding expectations by 126%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+291.94%
Avg 1-day reaction
+2.01%
Overall, investors are optimistic about Privia Health's upcoming earnings, especially given its strong track record of beating EPS estimates in recent quarters.
Bull case
If the company continues its trend of exceeding EPS expectations, it could signal robust operational performance and growth potential, leading to a positive stock reaction.
Bear case
On the other hand, if the company fails to provide clear revenue guidance or if EPS falls short of expectations, it could dampen investor sentiment and lead to a decline in stock price.
The print will turn on these.
Q1
What will the EPS be this quarter, and how does it compare to previous quarters?
Given the company's strong history of EPS surprises, this number will be critical in shaping investor expectations.
Q2
Will there be any guidance on revenue growth or market expansion?
Clear guidance on revenue will help investors gauge the company's future performance and growth trajectory.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±10.1%
Why consensus could be wrong
The Street may underestimate Privia's ability to sustain its growth trajectory, especially given its recent performance and market positioning.
Supporting evidence
The company has consistently beaten EPS estimates, indicating strong operational execution.
Options pricing suggests higher volatility, which could reflect underlying investor confidence in the company's fundamentals.
Key risk
If the EPS falls below $0.15, it could challenge the prevailing bullish sentiment.
Pre-commit to what would confirm each case.
This quarter's results will be pivotal in determining whether the company's growth trajectory continues or if it faces challenges.
Bull confirmed if
An EPS of $0.25 or higher would confirm the bullish case, suggesting strong operational performance.
Bear confirmed if
An EPS below $0.15 would confirm the bearish case, indicating potential issues in profitability.
What the market is pricing for the move.
Implied Move
±10.94%
Historical Avg
±5.4%
The options market is pricing in a significant move of nearly 11%, indicating that traders expect volatility around the earnings report.
Options are pricing ±10.9% while PRVA has averaged ±5.4% over the last 8 prints — setup is pricing rich.
ATM IV
0.5%
30d HV
28.0%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
98.53%
of float
Insider
6.19%
of float
Holders
399
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
21,402,417 sh · $434.5M
16.76%
12.3%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Privia beats expectations and raises guidance, history suggests the stock could rise by around 3.77%, confirming strong operational momentum.
In line / cautious
If results are in line with expectations but lack clear guidance, the stock may experience muted movement as investors reassess their outlook.
Miss
Should the company miss expectations, history indicates a potential decline of around 5.15%, reflecting investor disappointment.
The lines on the call that would change the story.
FMR, LLC
12,848,437 sh · $260.8M
10.06%
-1.5%
Durable Capital Partners Lp
11,635,948 sh · $236.2M
9.11%
-3.7%
Vanguard Portfolio Management LLC
6,572,384 sh · $133.4M
5.15%
4.6%
Rubicon Founders LLC
5,971,079 sh · $121.2M
4.67%
0.4%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.